Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease

10 Jul 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Muscle Physiology and Disorders
Share to Neurological disorders and treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22796360
DOI: 10.1016/j.nbd.2012.06.026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington diseasePMID 22796360Read ↗

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?Semantic proximity Read ↗

Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington’s diseaseSemantic proximity Read ↗

Effects of antipsychotics on the behavioral deficits in human dominant-negative DISC1 transgenic mice with neonatal polyI:C treatmentSemantic proximity Read ↗

Screening of Therapeutic Strategies for Huntington's Disease in YAC128 Transgenic MiceSemantic proximity Read ↗

An optimized “hypoxia in a pill” regimen reverses neurodegenerative disease phenotypes in multiple preclinical modelsSemantic proximity Read ↗

T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic miceSemantic proximity Read ↗

Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation.Semantic proximity Read ↗

Lithium Inhibits Neurite Growth and Tau Protein Kinase I/Glycogen Synthase Kinase‐3β‐Dependent Phosphorylation of Juvenile Tau in Cultured Hippocampal NeuronsSemantic proximity Read ↗

The Putative Use of Lithium in Alzheimer's DiseaseSemantic proximity Read ↗

Lithium reduces Gsk3b mRNA levels: implications for Alzheimer DiseaseSemantic proximity Read ↗

Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.Semantic proximity Read ↗

Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington’s Disease PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.